BioCryst Pharmaceuticals | BCRX - Market Capitalization


BioCryst Pharmaceuticals reported $1.79B in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alnylam Pharmaceuticals USD 52.54B 7.24B Dec/2025
BioCryst Pharmaceuticals USD 1.56B 14M Dec/2024
Chugai Pharma JPY 13.84T 3.01T Dec/2025
Daiichi Sankyo JPY 6.34T 62.51B Dec/2025
DBV Technologies USD 274M 17M Sep/2025
Enanta Pharmaceuticals USD 122M 98M Dec/2024
Gilead Sciences USD 152.28B 14.55B Dec/2025
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
Glaxosmithkline GBP 86.88B 7.29B Sep/2025
Incyte USD 19.39B 2.83B Dec/2025
Ionis Pharmaceuticals USD 12.81B 2.39B Dec/2025
Neurocrine Biosciences USD 14.14B 218M Dec/2025
PTC Therapeutics USD 6.1B 1.22B Dec/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sarepta Therapeutics USD 2.26B 238M Dec/2025
Ultragenyx Pharmaceutical USD 2.22B 680M Dec/2025
Vertex Pharmaceuticals USD 115.03B 14.61B Dec/2025